NIIMBL is looking for insights on universal connectivity systems and hybrid model federated learning systems to support #biopharmaceutical #manufacturing processes. Check out the two Requests for Information (RFIs) below and consider sharing them with your contacts and colleagues with knowledge of data science and computing systems. Universal Connectivity for In-process Analytics in Biopharmaceutical Manufacturing Submission Deadline: August 30, 2024 (5 pm ET) NIIMBL invites submissions from interested parties to share information on potential solutions for a Universal Connectivity System. This system is envisioned as an OT/IT core to facilitate seamless data integration and advanced analytics within biomanufacturing processes, thus enabling data-driven decision making and process optimization. Learn more: https://lnkd.in/epvQQp-7 Hybrid Model Federated Learning Request for Information Submission Deadline: September 23, 2024 (5 pm ET) This RFI seeks innovative approaches that combine Federated Learning with hybrid models (combining Physics-Based and AI/ML data-driven methodologies) specifically tailored for biopharmaceutical manufacturing processes. This request aims to gather insights and concepts for achieving integration and operationalization of these models in a practical, industry-relevant context. Learn more: https://lnkd.in/e4YV64Dk #datascience #machinelearning #ai #biopharma #biopharmaceuticals #data #dataanalytics #bigdata #dataintegration #IoT #ml #artificialintelligence
NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals
Biotechnology
Newark, DE 4,748 followers
American Innovation at Work
About us
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry. NIIMBL is part of Manufacturing USA®, a diverse network of federally-sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members.
- Website
-
http://www.niimbl.org
External link for NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Newark, DE
- Type
- Nonprofit
- Founded
- 2017
- Specialties
- Workforce development, Education and Training Programs, Biopharmaceuticals, Regulatory Standards, Biopharmaceutical Manufacturing, and biotechnology
Locations
-
Primary
15 Innovation Way
Newark, DE 19711, US
Employees at NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals
-
Lena Wu
Board Director | Strategic Advisor | CEO | Biotech & Analytical Tools Founder | Business/Corp Development
-
John Balchunas
Workforce Director at NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals
-
Joy Goswami
AUTM Chair Elect; Sr. Director, Corporate Engagement - Research, Translation & Education;
-
Seth Turner
Director of Information Technology at NIIMBL
Updates
-
2 days left to submit your application to host a hashtag #NIIMBLeXperience in 2025. Don't miss this chance to connect with talented students and introduce them to career possibilities in the hashtag #biopharma industry. The application deadline is this Thursday, July 25 at 5 pm ET. https://lnkd.in/eTXhzc8Y
-
-
Planning to attend Biotech Week Boston in September? Don't miss the Featured Talent Panel Discussion, Bridging the Skills Gap in the Biopharmaceutical Industry, on Wednesday, September 25. The discussion will feature strategies to recruit and develop talent for successful careers in the biopharma industry. The session will be moderated by workforce director John Balchunas. Panelists include: Angela Consani (Bioscience Core Skills Institute (BCSI) Jared Auclair (Northeastern University) Leslie Isenhour (Wake Technical Community College) Wendy S. Acton (Amgen) NIIMBL members can take advantage of special offers for the September 25 Exhibit Hall and Main Conference: https://lnkd.in/eytE-uQ3 Learn more about the conference: https://lnkd.in/dXzjV2w #BPIconf #biotech #bioprocessing #workforcedevelopment #biopharma
-
1 week left to submit your #NIIMBLeXperience regional host applications. Connect with talented students and share the multitude of careers options in the #biopharma industry by hosting a NIIMBL eXperience program next summer. Since its launch in 2019, the program has introduced nearly 140 college students to the biopharma industry. Play a vital role in shaping students' careers and strengthening the industry's talent pipeline. Applications are due July 25 at 5:00 pm ET. Learn more: https://lnkd.in/eTXhzc8Y
-
-
NIIMBL is proud to work with our fellow institutes across the U.S. to drive #manufacturing #innovation https://lnkd.in/epZqTcm7
Check out USMIC at usmic.org! Advancing US manufacturing together as a team!
Home - USMIC
https://usmic.org
-
In April, representatives from 70 organizations from across the #biopharma ecosystem gathered in Boston for the first U.S. Biopharma Workforce Partnership Conference. The event offered a chance to make new connections and form partnerships that will strengthen talent acquisition efforts within the #biopharmaceutical industry. It was a packed two days full of excitement, enthusiasm, and partnership as we look for ways to work together and build the biopharma workforce of the future. Check out the full recap video: https://lnkd.in/evkYQu6a #NIIMBLTalentPartnership #workforcedevelopment #NIIMBL
U.S. Biopharma Workforce Partnership Conference - April 17-18, 2024
https://www.youtube.com/
-
NIIMBL and The Open Applications Group have partnered to develop #biopharma #manufacturing ontologies as an open-source project, allowing for greater participation and adoption. Check out this recent article in Genetic Engineering & Biotechnology News highlighting this partnership and the benefits of #data standardization. https://lnkd.in/eFnZvUxp
NIIMBL and OAGi Team Up to Help Drug Industry Align on Data There is a lack of standardization when it comes to analytics. This partnership encourages adoption of common standards. The partnership—announced in June—will focus on a major source of variation in drug production says Roger Hart, PhD, NIIMBL senior fellow and Big Data project lead. NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals Open Applications Group
NIIMBL and OAGi Team Up to Help Drug Industry Align on Data
genengnews.com
-
What does the future of #biopharma #manufacturing look like? How do we get there? Our panel of experts from Cytiva, Boehringer Ingelheim, MilliporeSigma, Sartorius, and Vir Biotechnology, Inc. tackled those questions during our Visions and Challenges panel on Wednesday during the National Meeting.
-
-
Our 2024 NIIMBL National Meeting got off to a fantastic start yesterday with remarks for National Institute of Standards and Technology (NIST) Director Laurie Locascio, FDA Acting Chief Scientist David Strauss, and FDA CBER Director Peter Marks. Then, we had a full day of concurrent sessions focused on topics such as #bigdata, the #biopharma #manufacturing factory of the future, ontologies, inclusive #workforcedevelopment, and more. Our National Meeting brings the NIIMBL community together for plenty of thought-provoking discussion. We look forward much of the same this week in Washington, D.C. #biopharmaceuticals #biopharma #lifesciences #biomanufacturing #biotechnology #biotech
-
-
Our National Meeting week in Washington, D.C. kicked off with our Dancing with Venture event on Monday afternoon, connecting member small and medium-sized companies with venture capitalists in the #lifesciences. In addition to pitches from our SMM community and introductions from investors, the event featured fascinating perspectives and insights from our SMM panel discussion, fireside chat, and managing cash flow session. Thank you to our SMM panelists Nicole Merli, MBA, CRA (LumaCyte), Alina Alexeenko (LyoWave, Inc.), Erica Dawson (InDevR, Inc.), and Lena Wu (Phizzle), our Fireside Chat participants Daniella Kranjac (AVANT BIO) and John Bagdonas, CEP, FGE, NDEF (J.P. Morgan), and managing cash flow speakers Fletcher King and James Fitzgerald (Morgan Stanley), as well as our opening speaker Jorge Lamboy, PhD (National Institute of Standards and Technology (NIST) #biotech #biopharmaceuticals #biomanufacturing
-